Andréas Hartmann

5.4k total citations · 1 hit paper
47 papers, 3.4k citations indexed

About

Andréas Hartmann is a scholar working on Neurology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Andréas Hartmann has authored 47 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 22 papers in Cellular and Molecular Neuroscience and 12 papers in Clinical Psychology. Recurrent topics in Andréas Hartmann's work include Parkinson's Disease Mechanisms and Treatments (26 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Nerve injury and regeneration (10 papers). Andréas Hartmann is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (26 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Nerve injury and regeneration (10 papers). Andréas Hartmann collaborates with scholars based in France, Germany and United Kingdom. Andréas Hartmann's co-authors include Étienne C. Hirsch, Stéphane Hunot, Patrick P. Michel, Yves Agid, Daniel Alvarez‐Fischer, Annick Mouatt‐Prigent, Baptiste Faucheux, Merle Ruberg, Yulia Worbe and Anu Srinivasan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Andréas Hartmann

46 papers receiving 3.3k citations

Hit Papers

Caspase-3: A vulnerability factor and final effector in a... 2000 2026 2008 2017 2000 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
    2000 591 citations Andréas Hartmann, Stéphane Hunot et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andréas Hartmann France 30 1.6k 1.4k 1.0k 633 432 47 3.4k
Jack W. Lipton United States 36 1.5k 0.9× 1.8k 1.4× 830 0.8× 888 1.4× 362 0.8× 81 4.2k
James B. Koprich Canada 33 1.9k 1.2× 1.6k 1.2× 820 0.8× 545 0.9× 286 0.7× 63 3.2k
Janet Hoenicka Spain 26 2.2k 1.4× 1.6k 1.2× 868 0.8× 486 0.8× 321 0.7× 76 3.8k
Charles K. Meshul United States 39 1.7k 1.1× 2.7k 2.0× 1.5k 1.4× 523 0.8× 516 1.2× 130 4.9k
Pierre‐Olivier Fernagut France 39 3.0k 1.9× 2.4k 1.7× 1.2k 1.2× 909 1.4× 543 1.3× 90 5.1k
Habibeh Khoshbouei United States 36 608 0.4× 2.1k 1.5× 1.5k 1.4× 613 1.0× 367 0.8× 95 3.9k
Wayne A. Cass United States 39 1.6k 1.0× 3.5k 2.6× 1.7k 1.6× 811 1.3× 595 1.4× 82 5.5k
Veronica Ghiglieri Italy 37 2.3k 1.4× 2.7k 2.0× 1.0k 1.0× 792 1.3× 716 1.7× 78 4.8k
Patrick M. Abou‐Sleiman United Kingdom 23 2.2k 1.4× 1.2k 0.9× 1.4k 1.3× 681 1.1× 287 0.7× 36 3.7k
Marc Morissette Canada 43 2.2k 1.4× 3.0k 2.2× 1.1k 1.0× 319 0.5× 341 0.8× 132 5.4k

Countries citing papers authored by Andréas Hartmann

Since Specialization
Citations

This map shows the geographic impact of Andréas Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andréas Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andréas Hartmann more than expected).

Fields of papers citing papers by Andréas Hartmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andréas Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andréas Hartmann. The network helps show where Andréas Hartmann may publish in the future.

Co-authorship network of co-authors of Andréas Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andréas Hartmann. A scholar is included among the top collaborators of Andréas Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andréas Hartmann. Andréas Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zito, Giuseppe A., Cyril Atkinson-Clément, Benoît Béranger, et al.. (2025). Distinct cerebellar networks underpin clinical improvement in adolescent Tourette disorder. Brain. 1 indexed citations
2.
3.
Nilles, Christelle, Andréas Hartmann, Emmanuel Roze, Davide Martino, & Tamara Pringsheim. (2023). Tourette syndrome and other tic disorders of childhood. Handbook of clinical neurology. 196. 457–474. 4 indexed citations
4.
Atkinson-Clément, Cyril, Clément Tarrano, Charlotte Rosso, et al.. (2022). How does Tourette syndrome impact adolescents’ daily living? A text mining study. European Child & Adolescent Psychiatry. 32(12). 2623–2635. 8 indexed citations
5.
Salvador, Alexandre, Yulia Worbe, Cécile Delorme, et al.. (2017). Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome. Scientific Reports. 7(1). 6292–6292. 11 indexed citations
6.
Noelker, Carmen, Lydie Morel, Thomas Lescot, et al.. (2013). Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Scientific Reports. 3(1). 1393–1393. 136 indexed citations
7.
Alvarez‐Fischer, Daniel, Carmen Noelker, Franca Vulinović, et al.. (2013). Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model. PLoS ONE. 8(4). e61700–e61700. 101 indexed citations
8.
Karachi, Carine, David Grabli, Frédéric Bernard, et al.. (2010). Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. Journal of Clinical Investigation. 120(8). 2745–2754. 330 indexed citations
9.
Corvol, Jean‐Christophe, Cécilia Bonnet, Fanny Charbonnier‐Beaupel, et al.. (2010). The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial. Annals of Neurology. 69(1). 111–118. 75 indexed citations
10.
Pen, Gwenaëlle Le, Andréas Hartmann, Jean‐Charles Bizot, et al.. (2008). Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: A new genetic model for Parkinson's disease?. Parkinsonism & Related Disorders. 14. S107–S111. 16 indexed citations
11.
Schmidt, Liane, Baudouin Forgeot d’Arc, Gilles Lafargue, et al.. (2008). Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain. 131(5). 1303–1310. 140 indexed citations
12.
Alvarez‐Fischer, Daniel, Carmen Henze, Boris Ferger, et al.. (2007). Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice. Experimental Neurology. 210(1). 182–193. 135 indexed citations
13.
Pen, Gwenaëlle Le, Andréas Hartmann, Jean‐Charles Bizot, et al.. (2007). Progressive Loss of Dopaminergic Neurons in the Ventral Midbrain of Adult Mice Heterozygote forEngrailed1. Journal of Neuroscience. 27(5). 1063–1071. 117 indexed citations
14.
Lü, Lixia, Frauke Neff, Daniel Fischer, et al.. (2006). Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: A post-mortem study in human control subjects. Neurobiology of Disease. 23(2). 409–421. 21 indexed citations
15.
Henze, Carmen, Christopher D. Earl, Jürgen Sautter, et al.. (2005). Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. Brain Research. 1052(1). 97–104. 35 indexed citations
16.
Henze, Carmen, Thomas Lescot, Sabine Traver, et al.. (2005). Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro. Neuroscience Letters. 383(1-2). 44–48. 5 indexed citations
17.
Henze, Carmen, Andréas Hartmann, Thomas Lescot, Étienne C. Hirsch, & Patrick P. Michel. (2005). Proliferation of microglial cells induced by 1‐methyl‐4‐phenylpyridinium in mesencephalic cultures results from an astrocyte‐dependent mechanism: role of granulocyte macrophage colony‐stimulating factor. Journal of Neurochemistry. 95(4). 1069–1077. 28 indexed citations
18.
Lü, Lixia, Frauke Neff, Bernhard Hemmer, et al.. (2004). Gene expression profiles derived from single cells in human postmortem brain. Brain Research Protocols. 13(1). 18–25. 19 indexed citations
19.
Hartmann, Andréas, Patrick P. Michel, Jean‐Denis Troadec, et al.. (2001). Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?. Journal of Neurochemistry. 76(6). 1785–1793. 123 indexed citations
20.
Gu, Wen‐Jie, Véronique Blanchard, Chantal François, et al.. (2001). Parkin immunoreactivity in the brain of human and non‐human primates: An immunohistochemical analysis in normal conditions and in Parkinsonian syndromes. The Journal of Comparative Neurology. 432(2). 184–196. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jack W. Lipton Breakdown of academic impact, for papers by James B. Koprich Breakdown of academic impact, for papers by Janet Hoenicka Breakdown of academic impact, for papers by Charles K. Meshul Breakdown of academic impact, for papers by Pierre‐Olivier Fernagut Breakdown of academic impact, for papers by Habibeh Khoshbouei Breakdown of academic impact, for papers by Wayne A. Cass Breakdown of academic impact, for papers by Veronica Ghiglieri Breakdown of academic impact, for papers by Patrick M. Abou‐Sleiman Breakdown of academic impact, for papers by Marc Morissette
Rankless by CCL
2026